表紙
市場調査レポート

Azevan Pharmaceuticals, Inc.:製品パイプライン分析

Azevan Pharmaceuticals, Inc. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 321974
出版日 ページ情報 英文 25 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
Azevan Pharmaceuticals, Inc.:製品パイプライン分析 Azevan Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日: 2015年03月26日 ページ情報: 英文 25 Pages
概要

Azevan Pharmaceuticals, Inc. は、ストレス、気分、行動障害といった症状の治療のための小分子薬を開発するバイオ製薬会社です。同社の製品の対象疾患は、鬱病、治療抵抗性の鬱病、不安障害、心的外傷後ストレス障害、間欠性爆発性障害、 衝動的攻撃性、恐れ、暴力行為などです。

当レポートでは、Azevan Pharmaceuticals, Inc.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Azevan Pharmaceuticals, Inc.の基本情報

Azevan Pharmaceuticals, Inc.の概要

  • 主要情報
  • 企業情報

Azevan Pharmaceuticals, Inc.:R&Dの概要

  • 主な治療範囲

Azevan Pharmaceuticals, Inc.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Azevan Pharmaceuticals, Inc.:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

Azevan Pharmaceuticals, Inc.:薬剤プロファイル

  • SRX-246
  • SRX-251
  • AVN-628

Azevan Pharmaceuticals, Inc.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Azevan Pharmaceuticals, Inc.:最近のパイプライン動向

Azevan Pharmaceuticals, Inc.:休止中のプロジェクト

Azevan Pharmaceuticals, Inc.:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC06866CDB

Summary

Global Markets Direct's, 'Azevan Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Azevan Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Azevan Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Azevan Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Azevan Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Azevan Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Azevan Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Azevan Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Azevan Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Azevan Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Azevan Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Azevan Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Azevan Pharmaceuticals, Inc. Snapshot
    • Azevan Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Azevan Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Azevan Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Azevan Pharmaceuticals, Inc. - Pipeline Products Glance
    • Azevan Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Azevan Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Azevan Pharmaceuticals, Inc. - Drug Profiles
    • SRX-246
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SRX-251
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AVN-628
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Azevan Pharmaceuticals, Inc. - Pipeline Analysis
    • Azevan Pharmaceuticals, Inc. - Pipeline Products by Target
    • Azevan Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Azevan Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Azevan Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Azevan Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Azevan Pharmaceuticals, Inc. - Dormant Projects
  • Azevan Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Azevan Pharmaceuticals, Inc., Key Information
  • Azevan Pharmaceuticals, Inc., Key Facts
  • Azevan Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Azevan Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Azevan Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Azevan Pharmaceuticals, Inc. - Phase II, 2015
  • Azevan Pharmaceuticals, Inc. - Phase I, 2015
  • Azevan Pharmaceuticals, Inc. - Preclinical, 2015
  • Azevan Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Azevan Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
  • Azevan Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Azevan Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Azevan Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Azevan Pharmaceuticals, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Azevan Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
  • Azevan Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Azevan Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Azevan Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
  • Azevan Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Azevan Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Azevan Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top